Abstract
This study focused on an investigation of a high drug-loaded solid dispersion system consisting of drug, carrier, and surfactant. Solid dispersions of a water-insoluble ofloxacin (OFX) with polyethylene glycol (PEG) of different molecular weights, namely binary solid dispersion systems, were prepared at drug to carrier not less than 5∶5. Polysorbate 80, a nonionic surfactant, was incorporated into the binary solid dispersion systems as the third component to obtain the ternary solid dispersion systems. The powder x-ray diffraction and differential scanning calorimetric studies indicated that crystalline OFX existed in the solid dispersions with high drug loading. However, a decreased crystallinity of the solid dispersions obtained revealed that a portion of OFX was in an amorphous state. The results indicated a remarkably improved dissolution of drug from the ternary solid dispersion systems when compared with the binary solid dispersion systems. This was because of polysorbate 80, which improved wettability and solubilized the non-molecularly dispersed or crystalline fraction of OFX.
Keywords: ofloxacin, ternary solid dispersion, polysorbate 80, dissolution, drug loading
Full Text
The Full Text of this article is available as a PDF (238.4 KB).
References
- 1.Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion system. J Pharm Sci. 1971;60:1281–1302. doi: 10.1002/jps.2600600902. [DOI] [PubMed] [Google Scholar]
- 2.Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131–144. doi: 10.1016/S0378-5173(01)00891-2. [DOI] [PubMed] [Google Scholar]
- 3.Owusu-Ababio G, Ebube NK, Reams R, Habib M. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets. Pharm Dev Technol. 1998;3:405–412. doi: 10.3109/10837459809009868. [DOI] [PubMed] [Google Scholar]
- 4.Schachter DM, Xiong J. Solid state NMR perspective of drug-polymer solutions: a model system based on poly(ethylene oxide) Int J Pharm. 2006;281:89–101. doi: 10.1016/j.ijpharm.2004.05.024. [DOI] [PubMed] [Google Scholar]
- 5.Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2006;272:1–10. doi: 10.1016/j.ijpharm.2003.11.025. [DOI] [PubMed] [Google Scholar]
- 6.Suzuki H, Sunada H. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull (Tokyo). 1998;46:482–487. doi: 10.1248/cpb.46.482. [DOI] [PubMed] [Google Scholar]
- 7.Mura P, Faucci MT, Manderioli A, Bramanti G, Parrini P. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev Ind Pharm. 1999;25:257–264. doi: 10.1081/DDC-100102169. [DOI] [PubMed] [Google Scholar]
- 8.Okonogi S, Oguchi T, Yonemochi E, Puttipipatkhachorn S, Yamamoto K. Improved dissolution of ofloxacin via solid dispersion. Int J Pharm. 1997;156:175–180. doi: 10.1016/S0378-5173(97)00196-8. [DOI] [Google Scholar]
- 9.Craig DQM. Polyethylene glycol and drug release. Drug Dev Ind Pharm. 1990;16:2514–2515. doi: 10.3109/03639049009058544. [DOI] [Google Scholar]
- 10.Van den Mooter G, Augustijns P, Blaton N, Kinget R. Physicochemical charaterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm. 1998;164:67–80. doi: 10.1016/S0378-5173(97)00401-8. [DOI] [Google Scholar]
- 11.Puttipipatkhachorn S, Nunthanid J, Yamamoto K, Peck GE. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. J Control Release. 2001;75:143–153. doi: 10.1016/S0168-3659(01)00389-3. [DOI] [PubMed] [Google Scholar]
- 12.Morris KR, Knipp GT, Serajuddin ATM. Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle. J Pharm Sci. 1992;81:1185–1188. doi: 10.1002/jps.2600811212. [DOI] [PubMed] [Google Scholar]
- 13.Jachowicz R, Nurnberg E, Pieszczek B, Kluczykowska B, Maciejewska A. Solid dispersion of ketoprofen in pellets. Int J Pharm. 2000;206:13–21. doi: 10.1016/S0378-5173(00)00437-3. [DOI] [PubMed] [Google Scholar]
- 14.Okonogi S, Puttipipatkhachorn S, Yamamoto K. Thermal behavior of ursodeoxycholic acid in urea: identification of anomalous peak in thermal analysis. Drug Dev Ind Pharm. 2001;27:819–823. doi: 10.1081/DDC-100107245. [DOI] [PubMed] [Google Scholar]
- 15.Corrigan OI, Murphy CA, Timoney RP. Dissolution properties of polyethylene glycols and polyethylene glycol-drug systems. Int J Pharm. 1979;4:67–74. doi: 10.1016/0378-5173(79)90099-1. [DOI] [Google Scholar]
- 16.Luner PE, Babu SR, Mehta SC. Wettability of a hydrophobic drug by surfactant solution. Int J Pharm. 1996;128:29–44. doi: 10.1016/0378-5173(95)04208-3. [DOI] [Google Scholar]